Medtronic Plc
(NYSE : MDT)

( )
MDT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.31%610.121.0%$825.30m
DHRDanaher Corp. -0.21%324.360.7%$642.83m
ABTAbbott Laboratories -0.77%124.340.8%$542.57m
ISRGIntuitive Surgical, Inc. -0.15%1043.332.3%$528.28m
MDTMedtronic Plc -0.41%130.110.6%$463.90m
BDXBecton, Dickinson & Co. -0.21%253.281.0%$354.78m
ALGNAlign Technology, Inc. -0.26%725.246.3%$347.10m
BAXBaxter International, Inc. 0.12%80.891.8%$318.77m
IDXXIDEXX Laboratories, Inc. -0.43%679.643.8%$308.74m
DXCMDexCom, Inc. -2.09%560.747.8%$295.30m
HRCHill-Rom Holdings, Inc. -0.27%149.962.2%$293.62m
SYKStryker Corp. 0.23%276.801.3%$282.69m
BSXBoston Scientific Corp. -0.76%44.661.0%$258.58m
ZBHZimmer Biomet Holdings, Inc. 0.45%151.071.7%$237.68m
AAgilent Technologies, Inc. -0.26%172.321.6%$230.65m

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, coninuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.